IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 199 filers reported holding IMPAX LABORATORIES INC in Q3 2016. The put-call ratio across all filers is 1,411.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $5,105,000 | +17.0% | 262,451 | +0.1% | 0.01% | +25.0% |
| Q4 2017 | $4,365,000 | -4.9% | 262,176 | +15.9% | 0.00% | -20.0% |
| Q3 2017 | $4,591,000 | +36.4% | 226,168 | +8.2% | 0.01% | +25.0% |
| Q2 2017 | $3,367,000 | +78.3% | 209,117 | +40.1% | 0.00% | +33.3% |
| Q1 2017 | $1,888,000 | +80.0% | 149,249 | +88.4% | 0.00% | +200.0% |
| Q4 2016 | $1,049,000 | -36.4% | 79,205 | +13.8% | 0.00% | -50.0% |
| Q3 2016 | $1,650,000 | -28.2% | 69,605 | -12.7% | 0.00% | -50.0% |
| Q2 2016 | $2,299,000 | +31.1% | 79,755 | +45.7% | 0.00% | +33.3% |
| Q1 2016 | $1,753,000 | -30.5% | 54,749 | -7.2% | 0.00% | -25.0% |
| Q4 2015 | $2,521,000 | +13.4% | 58,968 | -6.6% | 0.00% | 0.0% |
| Q3 2015 | $2,224,000 | -46.2% | 63,167 | -29.8% | 0.00% | -50.0% |
| Q2 2015 | $4,131,000 | -6.4% | 89,951 | -4.5% | 0.01% | -11.1% |
| Q1 2015 | $4,413,000 | +42.6% | 94,147 | -3.6% | 0.01% | +28.6% |
| Q4 2014 | $3,094,000 | +44.9% | 97,653 | +8.4% | 0.01% | +40.0% |
| Q3 2014 | $2,136,000 | -16.1% | 90,097 | +6.1% | 0.01% | -16.7% |
| Q2 2014 | $2,546,000 | +12.2% | 84,886 | -1.2% | 0.01% | +20.0% |
| Q1 2014 | $2,270,000 | +8.2% | 85,935 | +3.0% | 0.01% | 0.0% |
| Q4 2013 | $2,098,000 | +27.3% | 83,455 | +3.7% | 0.01% | +25.0% |
| Q3 2013 | $1,648,000 | +4.3% | 80,504 | +1.6% | 0.00% | -20.0% |
| Q2 2013 | $1,580,000 | – | 79,241 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |